Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Journal of Experimental & Clinical Cancer Research : CR|December 1, 2020
Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinomaYuanzhuo Gu, Fubo Ji, Niya Liu, et al.
Gut|January 8, 2022
Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expressionFubo Ji, Jianjuan Zhang, Niya Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 12, 2026
CircRSU1 Activates the hnRNPA1/HIF-1α/CD24 Signaling Axis, Promoting Stemness Features of Hepatocellular CarcinomaShuting Xue, Danduo Wei, Yongzhi Zhao, et al.
Elife|October 18, 2022
Spatial modeling reveals nuclear phosphorylation and subcellular shuttling of YAP upon drug-induced liver injuryLilija Wehling, Liam Keegan, Paula Fernández-Palanca, et al.
British Journal of Cancer|September 6, 2022
Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesisAlphonse Charbel, Luca Tavernar, Thomas Albrecht, et al.
Molecular & Cellular Proteomics : MCP|January 25, 2018
Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC)Katarzyna Buczak, Alessandro Ori, Joanna M Kirkpatrick, et al.
Cancers|April 30, 2021
Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder CancerThomas Albrecht, Fritz Brinkmann, Michael Albrecht, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2013
BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinomaBenjamin Goeppert, Lena Frauenschuh, Marcus Renner, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 25, 2024
Oncogenic Roles of Laminin Subunit Gamma-2 in Intrahepatic Cholangiocarcinoma via Promoting EGFR TranslationJianjuan Zhang, Fubo Ji, Yaqi Tan, et al.
Epigenetics|September 6, 2016
Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinomaBenjamin Goeppert, Christina Ernst, Constance Baer, et al.
Pageof 12